Single-Photon Emission Computed Tomography (SPECT) Market Size Analysis and Top Companies
The global Single-Photon Emission Computed Tomography (SPECT) market size is estimated at to hit around USD 5.68 billion by 2033 from USD 3.17 billion in 2024 with a CAGR of 6.69% from 2024 to 2033. The top companies operating in the single-photon emission computed tomography (SPECT) market are Mediso Ltd, Siemens Healthcare AG, General Electric Co., Bruker Co., MiE GmbH, Digirad Corporation, Spectrum Dynamics Medical Inc and others.
Market Scope
| Report Coverage |
Details |
| Market Size in 2024 |
USD 3.17 Billion |
| Market Size by 2034 |
USD 6.06 Billion |
| Growth Rate from 2024 to 2034 |
CAGR of 6.69% |
| Base Year |
2023 |
| Forecast Period |
2024 to 2034 |
| Segments Covered |
By Type, By Product, By Application, and By End-User |
| Regions Covered |
North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Single-Photon Emission Computed Tomography (SPECT) Market Companies
- Mediso Ltd
- Siemens Healthcare AG
- General Electric Co.
- Bruker Co.
- MiE GmbH
- Digirad Corporation
- Spectrum Dynamics Medical Inc
Recent Developments
- In November 2022. GE Healthcare announced that the company has received expanded approval from the U.S. Food & Drug Administration for the use of its GE Healthcare DaTscan in patients with suspected dementia with Lewy bodies.
- In October 2022, Spectrum Dynamics announced its recent development in digital nuclear medicine imaging. New VERITON-CT-400 Series Digital SPECT/CT scanners are capable of imaging high-energy isotopes using solid state detector technology with wide-bore configuration.
- InOctober2022, Punjab Health and Family Welfare Ministry, India, approved the purchase of SPECT/CT, PET/CT scanner for Homi Bhabha Cancer Hospital.
- In June 2022, a leading company in SPECT market, Siemens Healthineers, announced that the company has received approval from the U.S. Food & Drug Administration (FDA) for new SPECT/CT scanner ‘Symbia Pro. Specta SPECT/CT scanner. This new SPECT/CT scanner offers a variety of enhanced capabilities including low dose CT up to 64 slices.
- In May 2022, a global leader in the diagnosis of cancer and other serious conditions, Swansea’s Singleton Hospital, received 4.1 million British pound state-of-the-art scanners investment. This investment will be utilized to purchase new SPECT/CT equipment that will help clinicians to spot cancer at early stage.
- In May 2022, a global player in SPECT market, Mediso Ltd announced that the company has planned to acquire Bartec Technologies Ltd. Bartes is a UK based company specializing in supply and installation of molecular imaging equipment and accessories.
We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344
